Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balbuena

Showing results (741-750 of 780) with videos related to

Pageof 78
Sort By:
JACC. Basic to Translational Science|August 16, 2016
Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation OutcomesYoshio Takemoto, Rafael J Ramirez, Miki Yokokawa, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectivenessBerenice A Silva, Alejandra Heriz, Jeremías Ayerbe, et al.
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|July 9, 2026
Implementation of a SARS-CoV-2 genomic surveillance network as a strategy to face other health challenges in PeruCarlos Padilla-Rojas, Verónica Hurtado, Wendy Lizarraga, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021María Dolores Chirlaque López, María Cabrerizo, Bernardo R Guzmán Herrador, et al.
Pageof 78

Showing results (741-750 of 780) with videos related to

Sort By:
Pageof 78
JACC. Basic to Translational Science|August 16, 2016
Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation OutcomesYoshio Takemoto, Rafael J Ramirez, Miki Yokokawa, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectivenessBerenice A Silva, Alejandra Heriz, Jeremías Ayerbe, et al.
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|July 9, 2026
Implementation of a SARS-CoV-2 genomic surveillance network as a strategy to face other health challenges in PeruCarlos Padilla-Rojas, Verónica Hurtado, Wendy Lizarraga, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021María Dolores Chirlaque López, María Cabrerizo, Bernardo R Guzmán Herrador, et al.
Pageof 78